Antacids for peptic ulcer: do we have anything better?

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Antacids with aluminium hydroxide show promise in accelerating duodenal ulcer healing.
• Evidence for gastric ulcer healing with antacids is less robust compared to duodenal ulcers.
• Comparative studies indicate antacids are comparable to H2 blockers for ulcer healing and symptom relief.

Purpose of the Study:

• To evaluate the efficacy of antacids in peptic ulcer treatment.
• To compare antacid efficacy with H2 blockers.
• To assess the role of antacids in current ulcer therapy.

Main Methods:

• Review of recent reports and studies on antacid efficacy.
• Comparison of antacid treatment with placebo and H2 blockers.
• Analysis of ulcer healing rates and symptom relief.

Main Results:

• Antacids accelerate duodenal ulcer healing; efficacy in gastric ulcers requires further study.
• Low-dose antacid regimens, particularly tablet formulations, are effective and convenient.
• Antacids demonstrate comparable efficacy to H2 blockers in healing and symptom relief.
• Side effects of low-dose antacids are typically mild, with aluminium accumulation a concern only in renal impairment.

Conclusions:

• Antacids, especially low-dose tablet formulations, are effective and convenient for peptic ulcer treatment.
• Antacids remain a cornerstone therapy for peptic ulcers, particularly in patients with healthy renal function.
• Further research may be needed to clarify antacid efficacy in gastric ulcers.